Stocks · Healthcare · Biotechnology
Bio-Techne Corporation TECH
$72.40 +0.00% Close, Oct 2, 2026 · NASDAQ · Market cap $11.34B
High qualityStrong trendLow risk
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $1.16, up 152.2% year over year.
- Operating margin widened to 20.7% from 8.4% a year earlier.
- The stock is in an uptrend: above its 200-day average for 71 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
Growth43Weak
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 29%
- EPS growth (TTM, YoY)Top 11%
- FCF growth (TTM, YoY)Bottom 43%
- Revenue growth, 3-year CAGRBottom 29%
- Revenue growth accelerationBottom 47%
Quality89Strong
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 19%
- Gross marginTop 49%
- Operating marginTop 13%
- Cash conversion (OCF / net income)Top 48%
- Accruals (lower is better)Bottom 38%
- Net debt / EBITDA (lower is better)Top 38%
- Interest coverTop 5%
Value65Positive
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 25%
- Free-cash-flow yieldTop 29%
- EBITDA / enterprise valueTop 30%
- Sales / enterprise valueBottom 32%
- P/E vs own 5-year history (lower is better)Bottom 46%
Momentum81Strong
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 49%
- 6-month returnTop 27%
- 1-year return vs S&P 500Top 43%
- Distance from 52-week highTop 1%
- Trend checklist (0–4)Top 7%
Revisions6Very weak
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 43%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyBottom 13%
- Upside to consensus price targetBottom 7%
Stability90Exceptional
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 1%
- Maximum drawdown, 3 yearsTop 22%
- Beta vs S&P 500 (lower is better)Top 32%
- Net debt / EBITDA (lower is better)Top 38%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 0.2% | -0.4% | ↓ |
| EPS growth (YoY) | -15.9% | 152.2% | ↑ |
| Gross margin | 64.8% | 65.8% | ↑ |
| Operating margin | 8.4% | 20.7% | ↑ |
| FCF margin | 21.0% | 21.7% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -0.4% | 0.2% | ↓ | Bottom 29% |
| EPS growth (TTM, YoY) | 152.2% | -15.9% | ↑ | Top 11% |
| Gross margin | 65.8% | 64.8% | ↑ | Top 49% |
| Operating margin | 20.7% | 8.4% | ↑ | Top 13% |
| Net margin | 15.0% | 6.0% | ↑ | — |
| Free-cash-flow margin | 21.7% | 21.0% | ↑ | — |
| Return on invested capital | 7.8% | — | Top 19% | |
| Revenue growth, 3-year CAGR | 2.2% | — | Bottom 29% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.61×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -4.3%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 3.4%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +5.1 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 0.07×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 46.6×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.44%
- Net buyback yield (TTM)
- -0.14%
- Shareholder yield
- 0.30%
- Share count change, 1 year
- +0.8%
- Share count change, 3-year CAGR
- -1.0%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 24, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- +0.8%
- Average 2-day reaction, last 8
- -0.9%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $65.78
- Target vs current price
- -9.1%
- Analysts with a rating
- 26
- Share rating Buy or Strong Buy
- 46%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 12, 2026 | +0.2% | +0.1% | +0.1% | +0.1% | — |
| May 6, 2026 | -3.6% | -16.4% | -16.3% | -10.3% | +27.2% |
| Feb 4, 2026 | +7.0% | +6.3% | +0.3% | -10.5% | -14.4% |
| Nov 5, 2025 | -0.3% | -1.9% | -3.1% | +4.5% | +6.8% |
| Aug 6, 2025 | +6.0% | -8.7% | -3.3% | -2.4% | +13.5% |
| May 7, 2025 | +9.8% | +2.2% | +8.2% | +4.5% | +15.0% |
| Feb 5, 2025 | +7.7% | +3.7% | -5.8% | -14.3% | -31.6% |
| Oct 30, 2024 | +10.5% | +7.5% | +9.7% | +5.8% | +5.5% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 12, 2026 | $0.52 | $0.52 | +0.2% | $321.2M |
| May 6, 2026 | $0.53 | $0.55 | -3.6% | $311.4M |
| Feb 4, 2026 | $0.46 | $0.43 | +7.0% | $295.9M |
| Nov 5, 2025 | $0.42 | $0.42 | -0.3% | $286.6M |
| Aug 6, 2025 | $0.53 | $0.50 | +6.0% | $317.0M |
| May 7, 2025 | $0.56 | $0.51 | +9.8% | $316.2M |
| Feb 5, 2025 | $0.42 | $0.39 | +7.7% | $297.0M |
| Oct 30, 2024 | $0.42 | $0.38 | +10.5% | $289.5M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 62.4× | 63.3× | 48th | Top 25% |
| P/E (forward) | 35.3× | — | — | — |
| EV / EBITDA | 33.1× | — | — | Top 30% |
| EV / Sales | 9.35× | — | — | Bottom 32% |
| Free-cash-flow yield | 2.32% | — | — | Top 29% |
| Earnings yield | 1.60% | — | — | Top 25% |
P/E over the past five years
Range 39.2× – 143.5× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +20.8%
- Earnings per share growth (TTM)
- +152.2%
- Change in P/E multiple
- -49.7%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 82
- Days above the 200-day average
- 71
- 50-day average slope (20 days)
- +0.6%
- 200-day average slope (20 days)
- +1.8%
- Distance from 50-day average
- +0.2%
- Distance from 200-day average
- +16.7%
- RSI (14)
- 55.5
- Relative volume
- 0.59×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 3.4%
- Volatility vs own 5-year history
- 0th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.80
- Correlation with S&P 500
- 0.28
- Current drawdown from 1-year high
- -0.3%
- Maximum drawdown, 3 years
- -48.5%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 24, 2021 | May 15, 2026 | -67.9% | 1164 days | Not yet recovered |
| Feb 16, 2021 | Mar 8, 2021 | -16.1% | 14 days | 25 days (Apr 13, 2021) |
| Apr 27, 2021 | May 17, 2021 | -12.2% | 14 days | 18 days (Jun 11, 2021) |
| Jan 20, 2021 | Jan 27, 2021 | -10.7% | 5 days | 4 days (Feb 2, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $11.34B
- P/E (TTM)
- 62.4
- EPS, diluted (TTM)
- $1.16
- Revenue (TTM)
- $1.22B
- Dividend yield
- 0.44%
- 52-week range
- $43.20 – $72.69
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Revenue | $1.11B | $1.14B | $1.16B | $1.22B | $1.22B |
| Gross profit | $756.5M | $769.8M | $769.7M | $790.3M | $799.1M |
| Operating income | $296.6M | $298.9M | $206.7M | $102.3M | $251.9M |
| Net income | $272.1M | $285.3M | $168.1M | $73.4M | $181.9M |
| EPS (diluted) | $1.66 | $1.76 | $1.05 | $0.46 | $1.16 |
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | Q4 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $289.5M | $297.0M | $316.2M | $317.0M | $286.6M | $295.9M | $311.4M | $321.2M |
| Net income | $33.6M | $34.9M | $22.6M | -$17.7M | $38.2M | $38.0M | $51.1M | $54.6M |
| EPS (diluted) | $0.21 | $0.22 | $0.14 | -$0.11 | $0.24 | $0.24 | $0.32 | $0.36 |
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Operating cash flow | $325.3M | $254.4M | $299.0M | $287.6M | $292.1M |
| Capital expenditure | -$44.9M | -$38.2M | -$62.9M | -$31.0M | -$28.9M |
| Free cash flow | $280.4M | $216.1M | $236.1M | $256.6M | $263.2M |
| Dividends paid | -$50.2M | -$50.3M | -$50.4M | -$50.4M | -$49.9M |
| Net share buybacks | -$160.9M | -$19.6M | -$80.0M | -$275.7M | $38.9M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $264.7M
- Total assets
- $2.59B
- Total liabilities
- $478.5M
- Total debt
- $289.1M
- Net debt
- $24.4M
- Shareholders’ equity
- $2.11B
As of Jun 30, 2026 (filed Aug 24, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Aug 24, 2026 | $0.08 | Sep 4, 2026 |
| May 18, 2026 | $0.08 | May 29, 2026 |
| Feb 13, 2026 | $0.08 | Feb 27, 2026 |
| Nov 17, 2025 | $0.08 | Nov 28, 2025 |
| Aug 18, 2025 | $0.08 | Aug 29, 2025 |
| May 19, 2025 | $0.08 | May 30, 2025 |
| Feb 14, 2025 | $0.08 | Feb 28, 2025 |
| Nov 8, 2024 | $0.08 | Nov 22, 2024 |
Short interest
- Shares sold short
- 6,627,623
- Days to cover
- 2.66
- Change vs previous report
- +12.5%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Nov 30, 2022
- 4-for-1
- Dec 4, 2000
- 2-for-1
- Nov 18, 1997
- 2-for-1